Similar articles

• Failure of ursodeoxycholic acid to prevent a cholestatic episode in a patient with benign recurrent intrahepatic cholestasis: a study of bile acid metabolism.

  Crosignani A, Podda M, Bertolini E, Battezzati PM, Zuin M, Setchell KD. Crosignani A, et al. Hepatology. 1991 Jun;13(6):1076-83. Hepatology. 1991. PMID: 2050325
• Treatment of patients with benign recurrent intrahepatic cholestasis.

  Bircher J. Bircher J. Hepatology. 1989 Dec;10(6):1030-2. doi: 10.1002/hep.1840100632. Hepatology. 1989. PMID: 2583683 No abstract available.
• Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy.

  van der Woerd WL, van Mil SW, Stapelbroek JM, Klomp LW, van de Graaf SF, Houwen RH. van der Woerd WL, et al. Best Pract Res Clin Gastroenterol. 2010 Oct;24(5):541-53. doi: 10.1016/j.bpg.2010.07.010. Best Pract Res Clin Gastroenterol. 2010. PMID: 20955958 Review.
• Benign recurrent intrahepatic cholestasis (BRIC) in an adult.

  Chhetri D, Gupta R, Duseja A, Dhiman RK, Chawla Y, Das A. Chhetri D, et al. Trop Gastroenterol. 2007 Oct-Dec;28(4):186-7. Trop Gastroenterol. 2007. PMID: 18416353
• Ursodeoxycholic acid: a promising hepatoprotectant in cholestatic liver diseases.

  Das K, Chawla YK. Das K, et al. Trop Gastroenterol. 1994 Oct-Dec;15(4):204-7. Trop Gastroenterol. 1994. PMID: 7618201 Review. No abstract available.